Aim We wanted to find out if roll-out of the bowel cancer screening programme (BCSP) across England was associated with a reduced risk of emergency hospital admission for people presenting with colorectal cancer (CRC) during this period.
Introduction
High rates of emergency admission at the time of cancer diagnosis have been a focus of concern in the UK despite over a decade of initiatives to promote earlier diagnosis [1] [2] [3] . In the case of colorectal cancer (CRC), emergency admission is associated with late-stage disease, a reduced chance of curative surgery and poorer survival compared with patients diagnosed electively [4] [5] [6] [7] . The rate of emergency admission for CRC in England between 1999 and 2006 was estimated at 32.5% [8] , consistent with the poorer outcomes observed for British patients relative to those in other European countries during this period [9, 10] .
The roll-out of the bowel cancer screening programme (BCSP) in England started in parts of the country in July 2006 and achieved nationwide coverage by January 2010. The programme offers faecal occult blood testing (FOBT) to all 60-69-year-olds and colonoscopy for those with positive results. Screening programmes are intended to detect cancers earlier so that there is better chance of successful therapy and subsequent survival. Although this concept is straightforward, screening for some cancers has proved controversial, with doubts about whether the overall gains from specific programmes warrant the cost or harm [11] [12] [13] .
In practice, quantifying the real-world benefits of population-based cancer screening is difficult. Survival benefit takes many years to realize [11, 14] and a range of other healthcare advances may occur over this period to confound the interpretation of national trends in cancer incidence or survival. In the case of CRC screening, a recent meta-analysis of trial data estimated that it took 10.3 years before one death from CRC was prevented for 1000 patients screened [14] .
Our study examined whether introduction of the BCSP across England was associated with a reduction in overall risk of emergency admission for CRC in the general population. Although a process measure, emergency admission is linked strongly to bowel cancer outcome [5] [6] [7] 15] and is therefore a useful surrogate for evaluating the early impact of the programme. There are a number of ways in which the implementation of screening should improve rates of elective diagnosis and reduce the risk of emergency admission. Firstly, the start-up of screening should lead to direct detection of asymptomatic cancers among people of screening age (screen-detected cases), thereby increasing the overall number of electively diagnosed cases in the population. Secondly, increased public and professional awareness of bowel cancer during the roll-out period may bring additional indirect benefits to the wider population. Raising awareness of colon cancer may encourage symptomatic patients to seek routine healthcare more readily and/or primary-care teams to refer more promptly for elective investigation. These indirect benefits may operate within a short time-scale (months not years) and impact on people of all ages, not only those members of the public targeted directly by screening.
Methods

Participants and setting
We studied patients of any age discharged with a diagnosis of CRC from an English National Health Service (NHS) hospital between October 2006 and September 2007, a 1-year period when the BCSP was rolling out across parts of the country.
Study design, data sources and time-scales
We used a retrospective cohort design (Fig. 1a, b) . At the beginning of the year of case-ascertainment (October 2006), the BCSP was active already in parts of England and became active in some but not all additional areas during the study year. Hence, there was variation in exposure to start-up of the BCSP between (and within) local populations during the period of study. This provided an opportunity for us to develop logistic regression models to estimate the association between start-up of BCSP in a patient's area and the risk of emergency admission during the diagnostic pathway.
Our analysis is based on patient-level data extracted from the Hospital Episode Statistics (HES) for England, a national data warehouse containing the information coded routinely at discharge for all inpatient care episodes occurring in NHS hospitals, including elective day-case procedures, elective admissions and unplanned (emergency) admissions [3] [4] [5] [6] [7] 16, 17] . We obtained administrative data for NHS hospitals for the 2 years relevant to the main period of roll-out of the English BCSP (2006/7 and 2007/8), merged the data and developed methods to identify a cohort of patients coded for the first time with CRC over the 1-year study period (1 October 2006 to 30 September 2007) .
During the study period, general practices in England were grouped administratively and geographically into primary-care trusts (PCTs) responsible for commissioning services for the local population. Information regarding the location and timing of start-up for each BCSP centre in England and the relevant PCT populations served by each centre was obtained [8, 18] . We generated a list identifying each PCT in England and the date when screening began in its local population. A small number of PCTs were associated with more than one screening centre, each having a different startup date. As it was not possible to allocate the entire PCT population to a verified single start-up date for local screening, we excluded these PCTs (n = 10). Hence, there were 142 PCTs included in the study; of these 17 PCTs had commenced screening before the beginning of the study period, 48 PCTs began active screening during the year of study and 77 PCTs had not yet started screening their local population by the end of the study period. The total adult population registered with general practitioners belonging to the study PCTs was 39 130 639 [9, 10, 19] .
Development of methods to extract incident cases of CRC
We developed linkage methods to extract a national cohort of CRC cases from the main HES dataset, identifying patients coded for the first time during the study period (Fig. 1a) . First, we identified all patients having one or more episodes containing a diagnostic code for CRC. Using the unique identifier for each cancer case we then extracted all of their care episodes from the main HES dataset and ordered them chronologically. Patients coded for the first time with CRC during the 1-year study period were identified as incident cases.
Identification of first relevant hospital episode (index episode) for each patient HES data do not contain a precise date of diagnosis and the first episode of care coded with a definitive cancer code is not a reliable starting point for the patient's journey as it is not always the patient's first relevant contact with the hospital [11] [12] [13] 17] . Manual review of the sequence of hospital episodes for individual cancer cases revealed that some patients had relevant hospital admissions recorded in the weeks prior to the first (index) coding of cancer. Relevant episodes included elective day-case endoscopic procedures or emergency admissions, where the recorded diagnosis was a nonspecific symptom code (e.g. constipation) or a nonmalignant diagnosis compatible with a patient undergoing investigation for cancer (e.g. iron-deficiency anaemia). We created algorithms to identify the first 'relevant' hospital episode for each patient, screening all coded primary diagnoses and procedures for any episodes recorded in the 6 months prior to the first coding of cancer. Lists of primary diagnoses or procedures regarded as relevant to the CRC diagnostic pathway were generated, based on steering group review of all codes identified in earlier episodes. The admission date for the first relevant admission was recorded for each case of CRC.
Primary outcome variable
The outcome of interest is emergency hospital admission during the diagnostic pathway. For each case of The cohort included all patients discharged with a diagnosis of colorectal cancer for the first time within the study period ( ), thereby excluding cases whose first hospital episode was before or after this period ( ). CRC, we used the recorded admission method (ADMI-METH field) for the patient's first relevant admission to define either an elective or emergency diagnostic pathway, as described previously [11, 14, 17] . HES data do not capture outpatient clinic attendances, but any patient having only elective hospital episodes before cancer coding would be categorized as having an elective pathway, including those whose first relevant admission was for elective definitive surgery. Hence, patients were categorized as having an emergency admission pathway if their first relevant admission was an unplanned hospitalization.
Patient exposure status (locally active BCSP)
The exposure of interest is the presence (or absence) of an active BCSP in the patient's local PCT area, quantified in terms of the length of time that the programme had been active prior to the patient's cancer diagnosis (Fig. 1b) . Each CRC case was assigned a variable to indicate whether or not the patient was living in a PCT that had active BCSP at the date of their first relevant admission. For those cases in which BCSP was active in the local population, we calculated the duration during which screening had been live in the area relative to the patient's index admission. In the base-case analysis, we categorized patients into three groups according to exposure status: (i) no active local screening at the time of index admission (the reference or 'unexposed' group); (ii) local screening active for less than 6 months; and (iii) local screening active for more than 6 months.
To further evaluate any 'dose-response' effect, we undertook sensitivity analysis using an alternative continuous exposure variable (duration of locally active BCSP, expressed in months). In addition, a subgroup analysis was undertaken which excluded cases living in any of the 77 PCTs that had not yet rolled out screening before the end of the study period. This subgroup analysis included only patients living in PCTs that had introduced local screening at some point prior to 30 September 2007.
Patient demographic, co-morbidity and socioeconomic variables A number of patient-level confounders needed to be considered when exploring possible factors associated with the risk of emergency admission for CRC. There is evidence to show that emergency admission is associated with increasing age, female gender, comorbidity and socio-economic deprivation [14, 18, 20] . We extracted the relevant data from HES for these case-mix variables, as described previously [5] [6] [7] [15] [16] [17] . Patients were allocated to the following age groups: < 60, 60-69 (the target age group for BCSP), 70-79 and ≥ 80 years. Comorbidity was based on the weighted Charlson score [17, 21] excluding the CRC diagnosis and categorized into three groups (none, score of 1, score ≥ 2). Patients were allocated to quintiles of deprivation based on their area of residence and the index of multiple deprivation, as described [8, 9, 22] .
Comparison with emergency admission rate for another form of cancer
We wanted to verify that any association demonstrated between the exposure of interest (a locally active BCSP) and emergency admission during the diagnostic pathway was specific to bowel cancer. Increased public and professional awareness of colon cancer as a result of start-up of local screening might act to reduce emergency admissions for CRC per se but would not be expected to have an impact on unrelated types of cancer. Indeed, if we did find a generalized association between active local BCSP and emergency admission for another form of cancer then this would suggest confounding -the exposure variable might be simply a surrogate marker for areas with superior access to elective services.
To exclude this possibility, we examined whether there was any relationship between active local BCSP and emergency admission rates for oesophageal and gastric cancers (OG cancer) using data from our recent study [15, 17] . The methods for extracting and validating the national data for OG cancer were similar to those described here for CRC and the study covered the relevant time period. Case-mix variables for OG cancer cases were comparable (age group, gender, comorbidity, deprivation quintile) and each patient had their index admission defined as either elective or emergency. Using the same approach applied to the CRC cases, we determined 'exposure' status for active BCSP for each OG cancer patient based on their PCT of residence and the date of their index admission. We predicted that there should be no association between the presence of a local BCSP and rates of emergency admission for OG cancer.
Analytical approach
Descriptive statistics were used to describe the characteristics of CRC patients overall and according to exposure status. We used binary logistic regression to provide crude (unadjusted) odds ratio, adjusted odds ratio and 95% CI for emergency admission as the dependent variable, as described [17] . We explored the association between emergency admission and the exposure of interest in three separate models: all CRC patients (i.e. all ages); patients in the screening age band specifically (60-69 years); and those falling outside the age band.
Results
National cohort of CRC cases identified from HES data
We identified 32 299 incident cases of CRC in England during the study year, which is comparable to an independent estimate of 33 604 new cases reported nationally in 2007 [23] . The patient characteristics of the national cohort are summarized in Table 1 . The age and gender distributions are consistent with previous reports [8, 23] . Based on our definition of emergency admission during the diagnostic pathway, there were 10 087 patients (36.5%) whose first relevant admission was an unplanned (emergency) hospitalization. This is comparable with an independent figure of 32.5% reported for England between 1999 and 2006 [8] .
CRC patients included in the study
Of the 32 299 new cases of CRC nationally, 27 763 patients belonged to one of the 142 PCTs included in the study. The characteristics of the patients from these PCTs were indistinguishable from the national cohort (Table 1) . With respect to the exposure of interest (local start-up of BCSP), 17 080 patients had their first relevant admission at a time when screening was not yet active in their local PCT population ('unexposed') and 7426 were diagnosed after the start-up date of screening in their locality ('exposed'). Of the 'exposed' group, 4222 patients had their first relevant admission within 6 months of the local start-up date and 3204 patients over 6 months after screening had started in their area, with a mean exposure time overall of 5.7 months (ranging from 0.1 to 15.2 months). It should be noted that only about half the target population of 60-69-yearolds would be offered screening in the first year of activation of the programme.
As shown in Table 1 , there was a very small but significant difference in mean age of patients across the three groups (no exposure, 71.0 years; < 6 months, 70.8 years; ≥ 6 months, 70.7 years; P < 0.01 ANOVA). This is consistent with a trend for slightly younger age of CRC cases diagnosed in an area where BCSP had become active. This may be explained by the predictable finding that the proportion of total CRC cases in the 60-69-year age group was higher for exposed versus unexposed groups -this confirms enhanced detection of prevalent cases of CRC among people of screening age either in the programme (asymptomatic, screendetected cases) or via normal diagnostic routes. There was no difference in gender mix or levels of comorbidity across the exposure groups. With respect to deprivation, the 'unexposed' group had the lowest proportion of CRC cases living in socioeconomically disadvantaged areas (quintile 1), i.e. they tended to be living in more affluent areas where the risk of emergency admission would be expected to be lower.
Crude rate of emergency admission by exposure status
Despite the imbalance in deprivation across the three groups, the crude rate of emergency admission was lowest in the group of CRC patients diagnosed when the BCSP had been active in their local population for ≥ 6 months (32.7%) and highest in the unexposed group of patients diagnosed before screening began in their area (37.1%; P < 0.001) ( Table 1 ). Those cases of CRC diagnosed within 6 months of local start-up of BCSP had an intermediate rate of emergency admission.
The difference in unadjusted rates of emergency admission with respect to exposure group was greatest in magnitude for CRC patients of screening age (60-69 years) but was also significant in patients falling outside the age targeted by the screening programme (Table 1) .
We excluded 4332 patients from the study since they belonged to PCTs served by more than one screening centre with different start dates for each centre. Although the precise exposure status of each individual case in these PCTs could not be determined, we do know that all but one of the ten excluded PCTs had rolled out screening before or during the study period. Hence, most of the excluded cases of CRC would have been 'exposed' to a local BCSP. Consistent with this, the overall rate of emergency admission for excluded cases was 33.1%, significantly lower than that of the unexposed cases in the study cohort (37.1%).
Identifying factors associated with emergency admission for CRC Logistic regression analysis (Table 2) confirmed that increasing age, female gender, increased levels of comorbidity and socioeconomic deprivation were associated with increased risk of emergency admission for CRC nationally, consistent with previous research [18, 20] . After adjusting for these case-mix factors in multiple regression, we were able to confirm that exposure status with respect to a locally active BCSP was an independent patient-level factor associated with emergency admission for CRC in England. Overall, the adjusted odds ratio for emergency admission in patients diagnosed ≥ 6 months after start-up of local screening was 0.83 (CI 0.76-0.90) compared with unexposed cases.
The 'protective' effect of the BCSP in terms of risk for emergency admission was not restricted to people of screening age, but extended across the whole population of bowel cancer cases presenting to the health service during this period. We constructed two separate models (see Table S1a ,b in the online Supporting Information), one that included only the 6719 CRC patients of screening age (60-69 years) and another that included the remaining 20 921 cases falling outside the target age for direct screening. For screening age cases, the adjusted odds ratio for emergency admission in patients diagnosed ≥ 6 months after screening started was 0.75 (CI 0.63-0.90). It was to be expected that the magnitude of risk reduction would be greatest for those aged 60-69 years since some of these patients will have had symptomless cancers detected within the screening programme, adding to any indirect effects that the launch of screening may have brought to symptomatic cases presenting via routine services. However, analysis of cases of CRC in patients outside the screening age showed that the adjusted odds ratio for emergency admission in patients diagnosed ≥ 6 months after screening started in their area was 0.85 (CI 0.77-0.94). This is consistent with our idea that local start-up of BCSP results in indirect, general benefits across the whole local population during this period. BCSP, Bowel Cancer Screening Programme; n.s., not significant. *The comparator groups for the given P-value. Of the total national cohort, 322 (1.0%) of patients had missing IMD (deprivation) status and were excluded from the analysis. There was a small but significant difference in age across the exposure groups (P < 0.001, ANOVA). As expected, the proportion of total cancer patients aged 60-69 years (screening age) was higher in the 'exposed' groups. The proportion of people living in least deprived areas was highest in the unexposed (no BCSP) group (P < 0.001, chi square). The crude rate of emergency admission was significantly lower in those diagnosed ≥ 6 months after start-up of the BCSP in their local population.
Sensitivity analyses
We substituted the categorical exposure variable (no BCSP; < 6 months; ≥ 6 months) for the actual duration (in months) that the BCSP had been active at the time of the patient's diagnosis. Using this continuous exposure variable, the adjusted odds ratio provides an estimate of risk reduction per month of exposure. These analyses confirmed an independent association between exposure time and risk of emergency admission for patients overall, those of screening age (60-69 years) and those outside this age group (Table 3) . To further explore potential confounding, we undertook a subgroup analysis in which we excluded all patients from the 77 PCTs that had not introduced screening at any point during the study period. The purpose of this analysis was to exclude any bias relating to possible systematic differences in rates of emergency admissions found in the 77 'late adopter 'PCTs compared with the PCTs that had rolled out bowel cancer screening before the end of our study period. Hence, in this subgroup analysis all patients belonged to one of the 65 PCTs that did roll out the BCSP prior to the end of the study year (30 September 2007). In this analysis there were 10 683 patients from 65 PCTs and, again, we confirmed an independent association between exposure status for BCSP and risk of emergency admission for CRC. For patients diagnosed ≥ 6 months after local start-up of the BCSP, the adjusted odds ratio for emergency admission was 0.76 overall (P < 0.001), 0.70 for those aged 60-69 years (P = 0.002) and 0.78 for other age groups (P < 0.001).
Comparison with emergency admissions for OG cancer
The characteristics of 22 450 patients diagnosed with OG cancer in England over a 2-year period (2006-2008) have been described [17] . Of these patients, 9319 belonged to the PCTs included in the present study and were diagnosed during the 1-year study period. Relative to their index admission, 6787 patients with OG cancer were diagnosed at a time when the BCSP was not active in their PCT ('unexposed') and 2532 were diagnosed after the BCSP started ('exposed'). Crude rates of emergency admission during the diagnostic pathway for OG cancer showed no difference across the exposure groups. The results of the binary logistic regression analysis are shown in Table 4 . We found no association between emergency admission rates of OG cancer and our predictor variable defining 'exposure' of the local population to BCSP. This suggests that exposure status is specifically associated with risk of emergency admission for CRC rather than for emergency admission for cancer or other conditions in general. This makes it unlikely that access to elective diagnosis in general was systematically 'better' in PCT populations where the programme became active earlier in the course of the national roll-out.
Discussion
We have demonstrated that the roll-out period of the BCSP across England was associated with a marked reduction in risk of emergency admission for CRC. The 'effect' was greatest among patients of screening age, where the risk of emergency admission in those diagnosed more than 6 months after local start-up of the programme was 0.75 times that of someone diagnosed before screening became active in their locality. However, what is of particular interest is that the risk reduction was not confined to the 60-69-year age groupthis suggests that indirect, population-wide benefits were operating as each area introduced screening. This is consistent with our hypothesis that the implementation of the BCSP would not only have an impact on individuals targeted for screening but would be associated with benefit across the local population by virtue of heightened public and professional awareness of bowel cancer. This is the first national study to show early and population-wide benefit arising from the introduction of the BCSP. Previous reports from specific parts of the country explored the impact of bowel cancer screening on overall emergency admissions for CRC. A randomized controlled trial assessing FOBT screening (the Nottingham Screening Study) compared 75 253 patients in the screened group (60% response rate) and 74 998 well matched, unscreened controls (age range 45-74 years). The emergency presentation rate was 23.9% in the screened group, compared with 27.9% in the control group, but the difference was not statistically significant (possibly due to the lack of study power) [24] . In an uncontrolled observational study from Coventry and North Warwickshire, where the bowel cancer screening pilot targeted a wider age group (50-69 years), the authors reported that 29.4% of CRC patients presented as an emergency in the year before the pilot (1999) but that the local rate had fallen to just 15.8% by 2004 . Surprisingly, the proportion of Dukes stage cancers was unchanged over the study period and the annual number of cases did not rise as might be expected if extra screen-detected cases were contributing to the reported totals [25] . Expert commentators questioned whether screening itself or other changes in local or national CRC care over the 5-year period were responsible for the time-trends reported [26] . Similar uncontrolled Results from three separate models (all age-groups combined; screening age only; other age groups). In all analyses, an association between exposure and reduced risk of emergency admission was confirmed after adjusting for age, gender, comorbidity and deprivation in multivariate binary logistic regression. The odds ratio (OR) expresses the reduction in risk per month of locally active screening.
local data for sigmoidoscopy-based colon cancer screening have shown a trend for reduced emergency admissions [27] . Our study has the advantage of nationwide coverage, large numbers and a design that sought to control for sources of bias. The staged roll-out of screening across the country meant that simple observation of temporal trends in annual emergency admission rates would not provide an accurate means of assessing the impact of the programme on unplanned care. Hence, we conceived a study design that took advantage of the variation in exposure between and within local populations to the potential benefits of start-up of BCSP during the roll-out period. Although our logistic regression models included key potential confounders, we cannot entirely eliminate the possibility of residual confounding given the observational nature of the work. Nevertheless, we undertook sensitivity and subgroup analyses and found consistent results. Furthermore, our analysis of 9319 cases of OG cancer diagnosed during the study period found no association between risk of emergency admissions for this unrelated tumour type and the local rollout of the BCSP. This excluded the possibility that our findings were due to nonspecific, generalized differences in hospital emergency admission rates between PCTs that rolled out screening early vs late.
We are not able to selectively quantify the indirect (as opposed to direct) benefits of the programme in our study since we cannot identify or exclude cases of screen-detected cancer (i.e. patients diagnosed directly by the programme after positive FOBT). Screening status is not recorded in HES data. Hence, we cannot know how much of the observed reduction in risk of emergency admission is attributable to the elective diagnosis of symptomless cancers within the programme itself. However, relative to the total number of new CRC cases diagnosed nationally, the absolute numbers of screen-detected tumours is low. In a report of cumulative findings from the BCSP up until October 2008 (a full year after the end of our study period), only 1772 screen-detected CRC cases had been recorded [28] . It follows that our study cohort of 27 763 cases will have contained only a few hundred screen-detected cancer patients.
Certainly, screen-detected cancers will have contributed in part to the reduced risk of emergency admission observed in the 60-69-year age group, but this cannot explain the fact that a major risk reduction is seen also in people outside the screening age. Moreover, we have shown a risk reduction within 6-12 months of start-up, when screening will have been offered to less than half of eligible 60-69-year-olds and hence the direct benefits of screen-detected cancers not yet fully realized. We anticipated that indirect benefits would operate mostly during the start-up and early phase of screening when local publicity and awareness of CRC was heightened, and we designed our study deliberately to focus on this period. The full impact of the BCSP will take some years to quantify, but the present study suggests that the introduction of screening has brought benefits that extend beyond those people targeted by and participating in the programme. These indirect benefits are likely to have translated into savings in acute hospital bed days and improvement in cancer outcomes. This strengthens the case supporting the cost-effectiveness of introducing bowel cancer screening in the UK health service setting. The roll-out of national screening based on FOBT has now been completed and services in England are preparing for implementation of screening with flexible sigmoidoscopy. It will be interesting to see whether this next phase is associated with similar population-wide benefits.
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